Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30795811 | 0.83 | GRM5 (0.60) | GRM5 | |
| SCHEMBL2010480 | 0.83 | GRM5 (0.60) | GRM5TSHR | |
| SCHEMBL30794402 | 0.80 | GRM5 (0.61) | GRM5 | |
| SCHEMBL2014419 | 0.77 | GRM5 (0.53) | GRM5TSHR | |
| SCHEMBL30796732 | 0.77 | GRM5 (0.53) | GRM5TSHR | |
| SCHEMBL158801 | 0.76 | TSHR (0.65) | GRM5TSHR | |
| SCHEMBL2013638 | 0.75 | GRM5 (0.74) | GRM5 | |
| SCHEMBL2011834 | 0.75 | GRM5 (1.00) | GRM5 | |
| SCHEMBL2009680 | 0.73 | GRM5 (0.74) | GRM5 | |
| SCHEMBL2013482 | 0.73 | GRM5 (0.60) | GRM5TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584250-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | Biohaven Therapeutics Ltd. (VG) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054811-A1 | COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS | BIOHAVEN THERAPEUTICS LTD. (VG) | 2024-03-14 | — | — | WO | disclosed |